Form 4: NeueHealth CFO Jay Matushak Executes Stock Transaction

NeueHealth's Chief Financial Officer, Jay Matushak, executed a transaction involving restricted stock units, resulting in a change in his beneficial ownership of the company's stock.

Summary

• Jay Matushak, the Chief Financial Officer of NeueHealth, Inc., engaged in a transaction involving restricted stock units on January 3, 2025.
• Mr. Matushak acquired 13,237 shares of common stock through the vesting of restricted stock units.
• Following the transaction, Mr. Matushak's direct ownership of common stock decreased by 22,717 shares.
• The restricted stock units vested on the second anniversary of the grant date, which was January 3, 2025.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing a stock transaction by an executive, which is neither positive nor negative in itself.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders when they have transactions involving company stock. It is a routine disclosure and does not indicate any specific trend in the industry.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the United States.
• The transaction is typical for executives who receive stock-based compensation.
• The vesting of restricted stock units is a common form of equity compensation.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects a change in ownership by a company executive.

Key Dates

Keywords

Form 4, Beneficial Ownership, Restricted Stock Units, Stock Transaction, Jay Matushak, NeueHealth, CFO